The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Repetitive Elements in Mammalian Telomeres Suppress Bacterial DNA-Induced Immune Activation
Open accessAbstract
Bacterial DNA contains immunostimulatory CpG motifs that trigger an innate immune response capable of promoting host survival following infectious challenge. Yet CpG-driven immune activation may also have deleterious consequences, ranging from autoimmune disease to death. We find that repetitive elements present at high frequency in mammalian telomeres, but rare in bacteria, down-regulate CpG-induced immune activation. Suppressive activity correlates with the ability of telomeric TTAGGG repeats to form G-tetrads. Colocalization of CpG DNA with Toll-like receptor 9 in endosomal vesicles is disrupted by these repetitive elements, although cellular binding and uptake remain unchanged. These findings are the first to establish that specific host-derived molecules can down-regulate the innate immune response elicited by a TLR ligand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
For Better or Worse? Telomerase Inhibition and Cancer
de Lange, T., & Jacks, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81955-8 · Cited by 119
Research works printed but not linked: 45
- 1992, J. Immunol., 4072
- 1996, Proc. Natl. Acad. Sci. USA, 2879
- 1998, Eur. J. Immunol., 2045
- 2000, Curr. Opin. Immunol., 35
- 2000, Nature, 740
- 2001, Proc. Natl. Acad. Sci. USA, 9237
- 2001, J. Immunol., 3555
- 1999, Immunity, 123
- 1999, J. Immunol., 2291
- 1999, Proc. Natl. Acad. Sci. USA, 6970
- 1989, J. Immunol., 1482
- 1997, Nature, 336
- 1997, Nat. Med., 829
- 1996, J. Immunol., 4570
- 2000, J. Immunol., 5683
- 1999, Nat. Med., 702
- 1995, Nature, 546
- 1987, Trends Genet., 342
- 1981, Prog. Nucleic Acid Res. Mol. Biol., 33
- 1998, Hum. Gene Ther., 1439
- 2000, Clin. Immunol., 198
- 2001, Gene Ther., 1024
- 1999, Cell, 273
- 1999, Genes Dev., 2353
- 1997, Cell, 25
- 1999, Cell, 701
- 1995, Science, 1601
- 1997, Springer. Semin. Immunopathol., 245
- 2000, Eur. J. Immunol., 108
- 1983, J. Immunol. Methods, 115
- 1988, Proc. Natl. Acad. Sci. USA, 6622
- 2000, Trends Pharmacol. Sci., 136
- 1994, EMBO J., 993
- 1995, J. Clin. Immunol., 284
- 1990, Arthritis Rheum., 1665
- 1998, J. Immunol., 2428
- 1998, J. Immunol., 3627
- 1998, Proc. Natl. Acad. Sci. USA, 12631
- 2003, J. Immunol., 3614
- 2002, J. Immunol., 5590
- 2001, Antisense Nucleic Acid Drug Dev., 247
- 1999, Annu. Rev. Immunol., 875
- 2000, Science, 84
- 2002, Arthritis Rheum., 2219
- 2002, Proc. Natl. Acad. Sci. USA, 8944
Cited by
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
Toll-like receptor function and signaling
Kaisho, T., & Akira, S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.023 · Cited by 898
Toll-like receptors in the pathogenesis of human disease
Cook, D. N., Pisetsky, D. S., & Schwartz, D. A. (2004) · Nature Immunology · doi:10.1038/ni1116 · Cited by 832
Beignon, A.-S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26032 · Cited by 673
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Vollmer, J., & Krieg, A. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.008 · Cited by 585
Aguilar, J. C., & Rodríguez, E. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.111 · Cited by 494
2′-O-methyl-modified RNAs Act as TLR7 Antagonists
Robbins, M., Judge, A., Liang, L., McClintock, K., Yaworski, E., & MacLachlan, I. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300240 · Cited by 336
Use of CpG oligodeoxynucleotides as immune adjuvants
Klinman, D. M., Currie, D., Gursel, I., & Verthelyi, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00148.x · Cited by 306
Self-citationThe DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
Haas, T., Metzger, J., Schmitz, F., Heit, A., Müller, T., Latz, E., & Wagner, H. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.013 · Cited by 298
Toll-like Receptors in the Vascular System: Sensing the Dangers Within
Goulopoulou, S., McCarthy, C. G., & Webb, R. C. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.010090 · Cited by 263
mRNA as gene therapeutic: How to control protein expression
Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses
Chan, Y. K., Wang, S. K., Chu, C. J., Copland, D. A., Letizia, A. J., Costa Verdera, H., Chiang, J. J., Sethi, M., Wang, M. K., Neidermyer, W. J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3438 · Cited by 215
“ODN TTAGGG, a well-known TLR9i sequence derived from mammalian telomeres (23), did not inhibit the activation of TLR7 or TLR2/6 (sensors of microbial RNA and lipoproteins, respectively) even at high concentration, supporting its specificity for TLR9 (fig.”
BackgroundInflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes
Bonafè, M., Prattichizzo, F., Giuliani, A., Storci, G., Sabbatinelli, J., & Olivieri, F. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.04.005 · Cited by 184
Kaminski, J. J., Schattgen, S. A., Tzeng, T.-C., Bode, C., Klinman, D. M., & Fitzgerald, K. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300530 · Cited by 112
“A151 has been shown to exert its suppressive effects through direct association with stimulatory CpG DNA as well as by disrupting STAT signaling pathways (17, 22).”
BackgroundSelf-citationSteinhagen, F., Zillinger, T., Peukert, K., Fox, M., Thudium, M., Barchet, W., Putensen, C., Klinman, D., Latz, E., & Bode, C. (2018) · European Journal of Immunology · doi:10.1002/eji.201747338 · Cited by 112
Self-citationCamões, S. P., Bulut, O., Yazar, V., Gaspar, M. M., Simões, S., Ferreira, R., Vitorino, R., Santos, J. M., Gursel, I., & Miranda, J. P. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.01.013 · Cited by 55
Lewis, H. D., Winter, A., Murphy, T. F., Tripathi, S., Pandey, V. N., & Barton, B. E. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0154 · Cited by 25
Metadata
- Authors
- Gursel, I., Gursel, M., Yamada, H., Ishii, K. J., Takeshita, F., & Klinman, D. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-01
- Volume
- 171
- Issue
- 3
- Pages
- 1393-1400
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2109403608
- Cited by
- 241
- References
- 6
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.